Literature DB >> 21028964

2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activity.

Natalya S Petrova Kruglova1, Mariya I Meschaninova, Alya G Venyaminova, Marina A Zenkova, Valentin V Vlassov, Elena L Chernolovskaya.   

Abstract

The thermodynamic asymmetry of siRNA duplexes determines their silencing activity. Favorable asymmetry can be achieved by incorporation of mismatches into the 3' part of the sense strand, providing fork-siRNAs, which exhibit higher silencing activity and higher sensitivity to nucleases. Recently, we found that selective 2'-O-methyl modifications of the nuclease-sensitive sites of siRNA significantly improve its nuclease resistance without substantial loss of silencing activity. Here, we examined the impact of nucleotide mismatches and the number and location of 2'-O-methyl modifications on the silencing activity and nuclease resistance of anti-MDR1 siRNAs. We found that both nonmodified and selectively modified fork-siRNAs with 4 mismatches at the 3' end of the sense strand suppress the expression of target gene at lower effective concentrations than the parent siRNAs with classical duplex design. The selective modification of nuclease-sensitive sites significantly improved the stability of fork-siRNAs in the presence of serum. The selectively modified fork-siRNA duplexes provided inhibitory effect over a period of 12 days posttransfection, whereas the gene silencing activity of the nonmodified analogs expired within 6 days. Thus, selective chemical modifications and structural alteration of siRNA duplexes improve their silencing properties and significantly prolong the duration of their silencing effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21028964     DOI: 10.1089/oli.2010.0246

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  5 in total

Review 1.  Regulation of small RNA stability: methylation and beyond.

Authors:  Lijuan Ji; Xuemei Chen
Journal:  Cell Res       Date:  2012-03-13       Impact factor: 25.617

Review 2.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

3.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

4.  Improved siRNA/shRNA functionality by mismatched duplex.

Authors:  Haoquan Wu; Hongming Ma; Chunting Ye; Danielle Ramirez; Shuiping Chen; Jessica Montoya; Premlata Shankar; Xiaozhong A Wang; N Manjunath
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

5.  Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance.

Authors:  Olga Patutina; Daria Chiglintseva; Elena Bichenkova; Svetlana Gaponova; Nadezhda Mironova; Valentin Vlassov; Marina Zenkova
Journal:  Molecules       Date:  2020-05-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.